Asosiy kontentga oʻtish
Maqola

Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

S. MallalCentre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Western Australia, Perth, Australia. [email protected]David NolanCentre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Western Australia, AustraliaCampbell S. WittDepartment of Clinical Immunology and Biochemical Genetics, Royal Perth HospitalG. MaselDepartment of Clinical Immunology and Biochemical Genetics, Royal Perth HospitalAM MartinCentre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Western Australia, AustraliaCorey MooreCentre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Western Australia, AustraliaD. SayerCentre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Western Australia, AustraliaA. CastleyDepartment of Clinical Immunology and Biochemical Genetics, Royal Perth HospitalCyril MamotteCentre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Western Australia, AustraliaDonald M. MaxwellCentre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Western Australia, AustraliaIan JamesRoyal Perth HospitalChristiansen FtDepartment of Pathology, University of Western Australia
2002en
ABI

Annotatsiya

Annotatsiya mavjud emas.

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba